Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel and Bupivacaine for Postoperative Analgesia in Lumbar Spine Surgery
NCT03514277Phase 4Terminated
- Sponsor
- Virtua Health
- Start
- Dec 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bupivacaine in postoperative pain, sponsored by Virtua Health. Primary endpoint: Mean Postoperative Pain Score at 3 days. Started Dec 2016; status: terminated.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03514277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03514277.